The governing Trust documents are:
On August 16, 2022, Endo International plc and certain of its subsidiaries initiated voluntary prearranged Chapter 11 proceedings in the U.S. Bankruptcy Court for the Southern District of New York (the “Bankruptcy Court”).
On March 22, 2024, the Bankruptcy Court entered an order [Docket No. 3960] (the “Confirmation Order”) confirming the Fourth Amended Joint Chapter 11 Plan of Reorganization of Endo International plc and its Affiliated Debtors [Docket No. 3849] (as modified, amended, or supplemented from time to time, the “Plan”).
On April 23, 2024, the Effective Date of the Plan occurred. All conditions precedent to the Effective Date of the Plan, as set forth in the Plan, were satisfied (or waived, as provided in the Plan), such that the Plan was substantially consummated.
Pursuant to the Plan and the Confirmation Order, the Endo Public Opioid Trust was established under the Endo Public Opioid Trust Agreement (the “Trust Agreement”) to:
Distributions in accordance with the Distribution Schedule are being implemented under the terms of the Plan, the Confirmation Order and the Trust Agreement under the direction of the Trustee, Bradley E. Scher.
The Endo Trustee is responsible for administering the Endo Public Opioid Trust, which includes managing the Trust’s assets, making distributions in accordance with the Trust Documents, and reporting annually as required by the Trust Documents.
The Endo Trustee is Bradley E. Scher.
The Endo Public Opioid Trust Beneficiaries are the States of the United States, the District of Columbia, and those territories of the United States identified in the Trust Documents.
Use the dropdown menu to access information related to each beneficiary.
The Endo Public Opioid Trust Beneficiaries are the States of the United States, the District of Columbia, and those territories of the United States identified in the Trust Documents.
Use the dropdown menu to access information related to each beneficiary.